PREDICTING DRUG-DRUG INTERACTION POTENTIAL BETWEEN VALPROIC ACID AND VIXOTRIGINE USING PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELING.

被引：0
|
作者：
Zhao, Y. [1 ]
Rooney, M. [1 ]
Naik, H. [1 ]
机构：
[1] Biogen Inc, 14 Cambridge Ctr, Cambridge, MA 02142 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2019年 / 105卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII-020
引用
收藏
页码：S48 / S48
页数：1
相关论文
共 50 条
  • [1] PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELING FOR ASSESSMENT OF THE DRUG-DRUG INTERACTION POTENTIAL OF ZAVEGEPANT
    Ke, A.
    Callegari, E.
    Bhardwaj, R.
    Varma, M.
    Muto, C.
    Bertz, R.
    Sahasrabudhe, V.
    Liu, J.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S107 - S107
  • [2] Evaluation of the drug-drug interaction potential of brigatinib using a physiologically-based pharmacokinetic modeling approach
    Hanley, Michael J.
    Yeo, Karen Rowland
    Tugnait, Meera
    Iwasaki, Shinji
    Narasimhan, Narayana
    Zhang, Pingkuan
    Venkatakrishnan, Karthik
    Gupta, Neeraj
    [J]. CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2024, 13 (04): : 624 - 637
  • [3] Physiologically-based pharmacokinetic model of sparsentan to evaluate drug-drug interaction potential
    Patel, Nikunjkumar K.
    Chen, Kuan-Fu
    Chen, Shang-Chiung
    Liu, Kai
    [J]. CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2024, 13 (02): : 317 - 329
  • [4] Prediction of drug-drug interaction potential using physiologically based pharmacokinetic modeling
    Min, Jee Sun
    Bae, Soo Kyung
    [J]. ARCHIVES OF PHARMACAL RESEARCH, 2017, 40 (12) : 1356 - 1379
  • [5] In vitro and physiologically-based pharmacokinetic based assessment of drug-drug interaction potential of canagliflozin
    Mamidi, Rao N. V. S.
    Dallas, Shannon
    Sensenhauser, Carlo
    Lim, Heng Keang
    Scheers, Ellen
    Verboven, Peter
    Cuyckens, Filip
    Leclercq, Laurent
    Evans, David C.
    Kelley, Michael F.
    Johnson, Mark D.
    Snoeys, Jan
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 83 (05) : 1082 - 1096
  • [6] Evaluation of the drug-drug interaction potential of treosulfan using a physiologically-based pharmacokinetic modelling approach
    Schaller, Stephan
    Martins, Frederico S.
    Balazki, Pavel
    Bohm, Sonja
    Baumgart, Joachim
    Hilger, Ralf A.
    Beelen, Dietrich W.
    Hemmelmann, Claudia
    Ring, Arne
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (04) : 1722 - 1734
  • [7] Physiologically-based pharmacokinetic modeling of the drug-drug interaction between ivacaftor and lefamulin in cystic fibrosis patients
    Amiel, Magali
    Ke, Alice
    Gelone, Steven P.
    Jones, Hannah M.
    Wicha, Wolfgang
    [J]. CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2024, 13 (04): : 589 - 598
  • [8] Response to in vitro and physiologically-based pharmacokinetic assessment of the drug-drug interaction potential of canagliflozin
    Miners, John O.
    Pattanawongsa, Attarat
    Rowland, Andrew
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 84 (02) : 392 - 393
  • [9] Evaluation of drug-drug interaction potential for pemigatinib using physiologically based pharmacokinetic modeling
    Ji, Tao
    Chen, Xuejun
    Yeleswaram, Swamy
    [J]. CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2022, 11 (07): : 894 - 905
  • [10] Physiologically based pharmacokinetic modeling of disposition and drug-drug interactions for valproic acid and divalproex
    Conner, Todd M.
    Nikolian, Vahagn C.
    Georgoff, Patrick E.
    Pai, Manjunath P.
    Alam, Hasan B.
    Sun, Duxin
    Reed, Ronald C.
    Zhang, Tao
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 111 : 465 - 481
12345